Perceptions about the efficacy of extended half-life (EHL) factor products in persons with haemophilia (PWH): A national survey of haemophilia providers from haemophilia treatment centres (HTCs) in the United States

Letter/Communication

Neeraja Swaminathan, Vanessa Salinas-Luna, Suchitra Acharya and Anjali Sharathkumar

Haemophilia : the official journal of the World Federation of Hemophilia, Vol.27(6), pp.e780-e783

11/2021

DOI: 10.1111/hae.14427

PMCID: PMC11984519

PMID: 34592042

Files and links (1)

url

https://www.ncbi.nlm.nih.gov/pmc/articles/11984519View

Open Access

United States

Factor VIII - therapeutic use

Half-Life

Hemophilia A - drug therapy

Hemophilia B

Humans

Title: Subtitle: Perceptions about the efficacy of extended half-life (EHL) factor products in persons with haemophilia (PWH): A national survey of haemophilia providers from haemophilia treatment centres (HTCs) in the United States
Creators: Neeraja Swaminathan - University of Iowa
Vanessa Salinas-Luna - Center for Inherited Blood Disorders
Suchitra Acharya - Northwell Health
Anjali Sharathkumar - Roy J. and Lucille A. Carver College of Medicine
Resource Type: Letter/Communication
Publication Details: Haemophilia : the official journal of the World Federation of Hemophilia, Vol.27(6), pp.e780-e783
DOI: 10.1111/hae.14427
PMID: 34592042
PMCID: PMC11984519
NLM abbreviation: Haemophilia
ISSN: 1351-8216
eISSN: 1365-2516
Grant note: T32 HL007344 / NHLBI NIH HHS
Language: English
Date published: 11/2021
Academic Unit: Stead Family Department of Pediatrics; Hematology/Oncology
Record Identifier: 9984353888002771

13 Record Views